Viatris (VTRS) Other Operating Expenses (2019 - 2026)

Viatris' (VTRS) quarterly Other Operating Expenses came in at -$53.5 million in Q1 2026, down 172.79% year-on-year from $73.5 million in Q1 2025, and down 1825.81% quarter-over-quarter from $3.1 million in Q4 2025.

Viatris (VTRS) Other Operating Expenses (2019 - 2026) Analysis & Trends

Viatris' Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$53.5 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses fell 172.79% year-over-year to -$53.5 million in Q1 2026; TTM through Mar 2026 was -$58.5 million, a 70.84% increase from a year earlier, with the FY2025 full-year figure at $68.5 million, up 119.52% from the prior year.
  • Other Operating Expenses declined to -$53.5 million in Q1 2026 per VTRS's latest filing, from $3.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $73.5 million in Q1 2025 and bottomed at -$148.1 million in Q4 2023.
  • The 5-year median for Other Operating Expenses is -$6.2 million (2022), against an average of -$26.6 million.
  • Across the five-year window, Other Operating Expenses jumped 569.23% in 2023 and sank 12700.0% in 2024, its largest moves.
  • Year by year, Other Operating Expenses stood at $8.8 million in 2022, then tumbled by 1782.95% to -$148.1 million in 2023, then climbed by 24.65% to -$111.6 million in 2024, then surged by 102.78% to $3.1 million in 2025, then sank by 1825.81% to -$53.5 million in 2026.
  • Per Business Quant, the three latest VTRS Other Operating Expenses figures stand at -$53.5 million (Q1 2026), $3.1 million (Q4 2025), and -$55.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -53.50 Mn
Dec 31, 2025 3.10 Mn
Sep 30, 2025 -55.70 Mn
Jun 30, 2025 47.60 Mn
Mar 31, 2025 73.50 Mn
Dec 31, 2024 -111.60 Mn
Sep 30, 2024 -31.50 Mn
Jun 30, 2024 -131.00 Mn
Mar 31, 2024 -76.80 Mn
Dec 31, 2023 -148.10 Mn
Sep 30, 2023 26.10 Mn
Jun 30, 2023 11.00 Mn
Mar 31, 2023 -600,000.00
Dec 31, 2022 8.80 Mn
Sep 30, 2022 3.90 Mn
Jun 30, 2022 -10.90 Mn
Mar 31, 2022 -6.20 Mn
Dec 31, 2021 -273.90 Mn
Sep 30, 2021 -9.40 Mn
Jun 30, 2021 -23.00 Mn